Abstract
Background and aims: The primary aim of the present review was to summarize the findings of genetic studies conducted on problem and pathological gambling. Method: Literature searches were conducted using PubMed, Medline and the HuGE Navigator databases using the keywords ‘gambling’ and ‘genetic*’. Results: The literature searches identified 21 empirical studies that had analyzed data from eight independent samples. Empirical research utilizing twin data accounted for eight of the studies, while gene association data were presented in 13 studies (including one genome wide-association study [GWAS] study). Twin studies emphasized the significant role of genetic and individual environmental factors in problem and pathological gambling. Gene association studies primarily reported the involvement of the dopaminergic and serotonergic systems. Discussion: Despite the relatively low number of genetic studies, the data clearly indicated the genetic vulnerability of problem and pathological gambling. Studies to date have mainly investigated and verified the role of factors reported to be important in other types of addiction, and it is suggested that pathological gambling should be included as a subtype of ‘Reward Deficiency Syndrome’ (RDS). It is concluded that future research should attempt to identify possible gambling specific susceptibility factors.
Keywords: Problem/pathological gambling, gambling addiction, behavioral addiction, systematic review, twin studies, genetic association studies, reward deficiency syndrome.
Current Pharmaceutical Design
Title:The Genetics of Problem and Pathological Gambling: A Systematic Review
Volume: 20 Issue: 25
Author(s): Agoston Gyollai, Mark D. Griffiths, Csaba Barta, Andrea Vereczkei, Robert Urban, Bernadette Kun, Gyongyi Kokonyei, Anna Szekely, Maria Sasvari-Szekely, Kenneth Blum and Zsolt Demetrovics
Affiliation:
Keywords: Problem/pathological gambling, gambling addiction, behavioral addiction, systematic review, twin studies, genetic association studies, reward deficiency syndrome.
Abstract: Background and aims: The primary aim of the present review was to summarize the findings of genetic studies conducted on problem and pathological gambling. Method: Literature searches were conducted using PubMed, Medline and the HuGE Navigator databases using the keywords ‘gambling’ and ‘genetic*’. Results: The literature searches identified 21 empirical studies that had analyzed data from eight independent samples. Empirical research utilizing twin data accounted for eight of the studies, while gene association data were presented in 13 studies (including one genome wide-association study [GWAS] study). Twin studies emphasized the significant role of genetic and individual environmental factors in problem and pathological gambling. Gene association studies primarily reported the involvement of the dopaminergic and serotonergic systems. Discussion: Despite the relatively low number of genetic studies, the data clearly indicated the genetic vulnerability of problem and pathological gambling. Studies to date have mainly investigated and verified the role of factors reported to be important in other types of addiction, and it is suggested that pathological gambling should be included as a subtype of ‘Reward Deficiency Syndrome’ (RDS). It is concluded that future research should attempt to identify possible gambling specific susceptibility factors.
Export Options
About this article
Cite this article as:
Gyollai Agoston, Griffiths D. Mark, Barta Csaba, Vereczkei Andrea, Urban Robert, Kun Bernadette, Kokonyei Gyongyi, Szekely Anna, Sasvari-Szekely Maria, Blum Kenneth and Demetrovics Zsolt, The Genetics of Problem and Pathological Gambling: A Systematic Review, Current Pharmaceutical Design 2014; 20 (25) . https://dx.doi.org/10.2174/13816128113199990626
DOI https://dx.doi.org/10.2174/13816128113199990626 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Layered Double Hydroxides as Flame Retardant and Thermal Stabilizer for Polymers
Recent Patents on Nanotechnology FDG-PET Scanning Shows Distributed Changes in Cortical Activity Associated with Visual Hallucinations in Eye Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Carbohydrate Mimotopes in the Rational Design of Cancer Vaccines
Current Topics in Medicinal Chemistry Novel Natural Agents from Lamiaceae Family: An Evaluation on Toxicity and Enzyme Inhibitory Potential Linked to Diabetes Mellitus
Current Bioactive Compounds Considering Autotaxin Inhibitors in Terms of 2D-QSAR and 3D-Mapping- Review and Evaluation
Current Medicinal Chemistry Sphingolipids in Inflammation: Roles and Implications
Current Molecular Medicine Quantitative Characterization of Phenotypical Markers After Differentiation of SH-SY5Y Cells
CNS & Neurological Disorders - Drug Targets Novel Mutation of the NOTCH3 Gene in a Chinese Pedigree with CADASIL
CNS & Neurological Disorders - Drug Targets “Ride or Die”: Therapeutic Interventions for Retaliatory Violence Among Youth
Adolescent Psychiatry Editorial (Thematic Issue: Glia: A New Cellular Target in the Treatment of Major Depression)
Current Drug Targets Sustained Release In Situ Implant of Arteether Based on Transition of Smedds into Lyotropic Liquid Crystalline Phases
Current Nanomedicine Crotylation of (R)-2,3-Cyclohexylideneglyceraldehyde: A Simple Strategy for the Synthesis of Enantiopure anti-Alzheimer (R)-Arundic Acid
Letters in Organic Chemistry Psychrophilic Bacteria: Biodiversity, Molecular Basis of Cold Adaptation and Biotechnological Implications
Current Biotechnology Editorial [Hot topic: Ocular Immunology (Guest Editor: Gerhild Wildner)]
Current Immunology Reviews (Discontinued) Metabolic Fate of Endocannabinoids
Current Neuropharmacology The Role of Circadian Rhythms in Fatal Arrhythmias and the Potential Impact of Intervention for Sleep-Disordered Breathing
Current Pharmaceutical Design Editorial [Hot Topic: New Insight in Obesity and Insulin Resistance (Guest Editor: Geltrude Mingrone)]
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Minocycline: Neuroprotective Mechanisms in Parkinsons Disease
Current Pharmaceutical Design Cell Transplantation: A Future Therapy for Narcolepsy?
CNS & Neurological Disorders - Drug Targets Role of Metal Ions in the Aβ Oligomerization in Alzheimers Disease and in Other Neurological Disorders
Current Alzheimer Research